Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Query: "AREA[SponsorSearch](EA Pharma Co., Ltd.)"
Count: 15
Selected: 0
NCT IDTitle
NCT03531892A Study to Evaluate the Safety and Efficacy of AJM300 in Participants With Active Ulcerative Colitis
NCT04223960A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, Bioavailability, and Food-effects of EA1080 in Healthy Caucasian and Japanese Male Participants
NCT03922633A Single Intravenous Dose of E3112 in Japanese Healthy Adult Male Participants
NCT03733314A Study of E6011 in Participants With Active Crohn's Disease
NCT03444818A Study to Determine the Absorption, Metabolism, and Excretion of [14C]-E6007 After a Single Oral Administration in Healthy Male Participants
NCT03390647A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics in Healthy Adult Male Participants
NCT03133468Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AJM347 in Healthy Male Caucasian and Japanese Subjects in the Fasted and Fed State
NCT03092765Study of E6011 in Japanese Subjects With Primary Biliary Cholangitis Inadequately Responding to Ursodeoxycholic Acid
NCT03018054Study of E6007 in Japanese Patients With Moderate Active Ulcerative Colitis
NCT03014895A Single Intravenous Dose Study of E3112 in Japanese Healthy Adult Male Subjects
NCT02961556General Clinical Study of AJG555 in Pediatric Patients With Chronic Constipation
NCT02902978A Single Dose Study of E6130 in Japanese Healthy Adult Male Subjects
NCT02039063A Phase 1/2 Study of Repeated Intravenous E6011 Administration in Japanese Subjects With Crohn's Disease
NCT04235205Efficacy and Safety of Elobixibat in Combination With Cholestyramine for Nonalcoholic Fatty Liver Disease
NCT02063854A Phase II/III, Double-blind, Parallel Group Comparative Study of Oral Administration of NE-58095 Tablets